Enzyme Replacement Therapy (ERT) on Heart Function Changes the Outcome in Patients with Infantile-Onset Pompe Disease: A Familial History
Background. Lysosomal acid alpha-glucosidase (GAA) deficiency, also known as Pompe disease, is an autosomal recessive disorder that leads to the accumulation of glycogen in lysosomes and cytoplasm, resulting in tissue destruction. Infantile-onset GAA deficiency is characterized by cardiomyopathy and...
Saved in:
| Main Authors: | Marco Lecis, Katia Rossi, Maria Elena Guerzoni, Ilaria Mariotti, Lorenzo Iughetti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Case Reports in Pediatrics |
| Online Access: | http://dx.doi.org/10.1155/2023/8470341 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical manifestations in Egyptian Pompe disease patients: Molecular variability and enzyme replacement therapy (ERT) outcomes
by: Mohamed Abdelghafar Hussein, et al.
Published: (2025-01-01) -
An uncommon case of neonatal asphyxia associated with infantile-onset Pompe disease
by: Francesco Leo, et al.
Published: (2025-08-01) -
Late-onset Pompe disease: preliminary results of enzyme replacement therapy
by: L. P. Smertina, et al.
Published: (2019-07-01) -
Optimizing clinical outcomes: The journey of twins with CRIM-negative infantile-onset Pompe disease on high-dose enzyme replacement therapy and immunomodulation
by: Angie H. Fares, et al.
Published: (2024-12-01) -
Infantile-onset Pompe disease (the first case diagnosed in Voronezh)
by: V. P. Fedotov, et al.
Published: (2015-02-01)